TY - JOUR T1 - Global left ventricular longitudinal systolic strain as a major predictor of cardiovascular events in patients with atrial fibrillation JF - Heart JO - Heart SP - 1588 LP - 1596 DO - 10.1136/heartjnl-2013-304561 VL - 99 IS - 21 AU - Ho-Ming Su AU - Tsung-Hsien Lin AU - Po-Chao Hsu AU - Wen-Hsien Lee AU - Chun-Yuan Chu AU - Chee-Siong Lee AU - Wen-Chol Voon AU - Wen-Ter Lai AU - Sheng-Hsiung Sheu Y1 - 2013/11/01 UR - http://heart.bmj.com/content/99/21/1588.abstract N2 - Objective Although global left ventricular longitudinal systolic strain (GLS) is a sensitive measure of left ventricular mechanics, its relationship with adverse cardiovascular (CV) events in atrial fibrillation (AF) has not been evaluated. This study sought to examine the ability of GLS in predicting CV events in AF. Design Observational cohort study. Setting Department of cardiology in a university hospital. Patients 196 persistent AF patients referred for echocardiographic examination. Main outcome measures The risk of GLS measured by index beat method for CV events was assessed by Cox proportional hazards analyses. CV events were defined as CV death, non-fatal stroke and hospitalisation for heart failure. Results There were 19 CV deaths, 12 non-fatal stroke and 28 hospitalisations for heart failure during an average follow-up of 21±10 months. Multivariate analysis showed worsening GLS (HR 1.121; 95% CI 1.023 to 1.228, p=0.014) was independently associated with increased CV events. In direct comparison, GLS outperformed left ventricular ejection fraction (LVEF) and systolic mitral annulus velocity (Sa) in predicting adverse CV events both in univariate and multivariate models (p≤0.043). Besides, the addition of GLS to a Cox model containing chronic heart failure, hypertension, age ≥75 years, diabetes, prior stroke score, estimated glomerular filtration rate, LVEF and Sa provided an additional benefit in the prediction of adverse CV events (p=0.022). Conclusions GLS was a major parameter and stronger than LVEF and Sa in predicting adverse CV events and could offer an additional prognostic benefit over conventional clinical and echocardiographic systolic parameters in AF. ER -